These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 3675160)

  • 1. Influence of derivatisation of the hydroxy groups in 1,1-bis-(4-hydroxyphenyl)-2-phenylbut-1-ene on estradiol receptor affinity and mammary tumor inhibiting properties.
    Schuderer ML; Schneider MR
    Arch Pharm (Weinheim); 1987 Jul; 320(7):635-41. PubMed ID: 3675160
    [No Abstract]   [Full Text] [Related]  

  • 2. Mammary tumor inhibiting effect of 3,3'-diacetoxy-alpha, beta-dialkylstilbenes and of related stilbene oxides.
    Schneider MR; Schönenberger H; Michel RT; Fortmeyer HP
    J Med Chem; 1982 Feb; 25(2):141-5. PubMed ID: 7057418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1-[4-(N,N-bis-beta-chloroethylcarbamoyloxy)-phenyl]-1,2-bis- (hydroxyphenyl)-but-1-enes: drugs specifically targeted against estrogen receptor positive mammary tumors.
    Schneider MR; Schuderer ML
    Arch Pharm (Weinheim); 1990 Apr; 323(4):215-9. PubMed ID: 2360864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytotoxic ester derivatives of the mammary tumor inhibiting antiestrogen 2,3-bis(2-fluoro-4-hydroxyphenyl)-2,3-dimethylbutane.
    Schwarz W; Hartmann RW; Engel J; Schneider MR; Schönenberger H
    Arch Pharm (Weinheim); 1990 Feb; 323(2):121-4. PubMed ID: 2159273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ring-substituted 1,1,2,2-tetraalkylated 1,2-bis(hydroxyphenyl)ethanes. 4. Synthesis, estrogen receptor binding affinity, and evaluation of antiestrogenic and mammary tumor inhibiting activity of symmetrically disubstituted 1,1,2,2-tetramethyl-1,2-bis(hydroxyphenyl)ethanes.
    Hartmann RW; Schwarz W; Heindl A; Schönenberger H
    J Med Chem; 1985 Sep; 28(9):1295-301. PubMed ID: 2993619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Mammary-tumor-inhibiting antiestrogens of the 3,3'-dihydroxy-alpha, beta-dialkylstilbene type (author's transl)].
    Schneider M; von Angerer E; Kranzfelder G; Schönenberger H
    Arch Pharm (Weinheim); 1980; 313(11):919-25. PubMed ID: 7447652
    [No Abstract]   [Full Text] [Related]  

  • 7. Ring-substituted 1,2-dialkylated 1,2-bis(hydroxyphenyl)ethanes. 3. Synthesis, estrogen receptor binding affinity, and evaluation of antiestrogenic and mammary tumor inhibiting activity of 2,2'-disubstituted butestrols and 6,6'-disubstituted metabutestrols.
    Hartmann RW; Heindl A; Schwarz W; Schönenberger H
    J Med Chem; 1984 Jul; 27(7):819-24. PubMed ID: 6330356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of alkyl-chain fluorination on the action of mammary tumor inhibiting 2,3-bis(hydroxyphenyl)butanes and 2,3-bis(hydroxyphenyl)but-2-enes.
    Hartmann RW; Heindl A; Schneider MR; Schönenberger H
    J Med Chem; 1986 Mar; 29(3):322-8. PubMed ID: 3005573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 1,1,2-triphenylbut-1-enes: relationship between structure, estradiol receptor affinity, and mammary tumor inhibiting properties.
    Schneider MR; von Angerer E; Schönenberger H; Michel RT; Fortmeyer HP
    J Med Chem; 1982 Sep; 25(9):1070-7. PubMed ID: 6813499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platinum complexes with a selective action on estrogen receptor-positive mammary tumors.
    von Angerer E; Birnböck H; Knebel N
    Anticancer Drug Des; 1989 Jun; 4(1):21-35. PubMed ID: 2757751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N,N'-Dialkyl-1,2-bis(hydroxyphenyl)ethylenediamines and N,N-dialkyl-4,5-bis(4-hydroxyphenyl)imidazolidines: syntheses and evaluation of their mammary tumor inhibiting activity.
    von Angerer E; Egginger G; Kranzfelder G; Bernhauer H; Schönenberger H
    J Med Chem; 1982 Jul; 25(7):832-7. PubMed ID: 6809943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aqua[1,1-bis(4-hydroxyphenyl)-1,2-diamino-2-phenylethane]- sulfatoplatinum(II), a new compound for the treatment of the mammary carcinoma.
    Gust R
    Arch Pharm (Weinheim); 1994 Jan; 327(1):49-54. PubMed ID: 8117188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 2-Alkyl-substituted 1,1-bis(4-acetoxyphenyl)-2-phenylethenes. Estrogen receptor affinity, estrogenic and antiestrogenic properties, and mammary tumor inhibiting activity.
    Schneider MR
    J Med Chem; 1986 Aug; 29(8):1494-8. PubMed ID: 3735317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytotoxic esters of 1,1-bis-(4-hydroxyphenyl)-2-phenyl-but-1-ene with selective antitumor activity against estrogen receptor-containing mammary tumors.
    Schuderer ML; Schneider MR
    J Cancer Res Clin Oncol; 1987; 113(3):230-4. PubMed ID: 3584214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2-Phenylbenzo[b]furans: relationship between structure, estrogen receptor affinity and cytostatic activity against mammary tumor cells.
    Erber S; Ringshandl R; von Angerer E
    Anticancer Drug Des; 1991 Nov; 6(5):417-26. PubMed ID: 1764164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiestrogens. Synthesis and evaluation of mammary tumor inhibiting activity of 1,1,2,2-tetraalkyl-1,2 -diphenylethanes.
    Hartmann RW; Kranzfelder G; von Angerer E; Schönenberger H
    J Med Chem; 1980 Aug; 23(8):841-8. PubMed ID: 7401112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 2-(Hydroxyphenyl)indoles: a new class of mammary tumor inhibiting compounds.
    von Angerer E; Prekajac J
    J Med Chem; 1983 Jan; 26(1):113-6. PubMed ID: 6402593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigations on estrogen receptor binding. The estrogenic, antiestrogenic, and cytotoxic properties of C2-alkyl-substituted 1,1-bis(4-hydroxyphenyl)-2-phenylethenes.
    Lubczyk V; Bachmann H; Gust R
    J Med Chem; 2002 Nov; 45(24):5358-64. PubMed ID: 12431063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 2-Phenylindoles. Effect of N-benzylation on estrogen receptor affinity, estrogenic properties, and mammary tumor inhibiting activity.
    von Angerer E; Strohmeier J
    J Med Chem; 1987 Jan; 30(1):131-6. PubMed ID: 3806590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 2-Phenylindenes: development of a new mammary tumor inhibiting antiestrogen by combination of estrogenic side effect lowering structural elements.
    Schneider MR; Ball H
    J Med Chem; 1986 Jan; 29(1):75-9. PubMed ID: 3941415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.